Advancements in CAR T-Cell Therapy for Autoimmune Diseases: A New Frontier The landscape of autoimmune disease treatment is undergoing a significant transformation. While chimeric antigen receptor (CAR) T-cell therapy has …
Tag:
Financings
-
-
Orthogon Biosciences Targets Viral Capsid Protein VP1 for Next-Generation Antiviral Therapy Orthogon Biosciences is advancing a novel antiviral strategy that directly targets the viral capsid protein VP1, a critical component …